CONTROLLED TRIAL OF BROMOCRIPTINE, QUINŒSTROL, AND PLACEBO IN SUPPRESSION OF PUERPERAL LACTATION

This publication has 12 references indexed in Scilit:

• THE ROLE OF PROLACTIN IN THE RESTORATION OF OVARIAN FUNCTION DURING THE EARLY POST‐PARTUM PERIOD IN THE HUMAN FEMALE
  Clinical Endocrinology, 1975
• A NEW APPROACH TO THE INHIBITION OF PUERPERAL LACTATION
  BJOG: An International Journal of Obstetrics and Gynaecology, 1973
• Radioimmunoassay for Human Pituitary Prolactin, Using Antiserum against an Extract of Human Amniotic Fluid
  Hormone Research, 1973
• THE INHIBITION OF PROLACTIN SECRETION IN MAN BY CB-154 (2-Br-α-ergocryptine)
  Journal of Clinical Endocrinology & Metabolism, 1972
• Galactorrhoea: Successful Treatment with Reduction of Plasma Prolactin Levels by Brom-ergocryptine
  BMJ, 1972
• Suppression of Puerperal Lactation with an Ergot Alkaloid: A Double-blind Study
  BMJ, 1972
• Treatment of Non-puerperal Galactorrhoea with an Ergot Alkaloid
  BMJ, 1971
• Puerperal Thromboembolism in Relation to the Inhibition of Lactation by Oestrogen Therapy
  BMJ, 1968
• PUERPERAL THROMBOEMBOLISM AND SUPPRESSION OF LACTATION
  The Lancet, 1967
• SUPPRESSION OF LACTATION BY STILBŒSTROL
  The Lancet, 1967